Metabolically healthy and unhealthy obesity phenotypes in the general population: The FIN-D2D Survey

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Pajunen, Pia ^a   Kotronen, Anna ^a,b,c   Korpi Hyövälti, Eeva ^d   Keinänen Kiukaanniemi, Sirkka ^e,f   Oksa, Heikki ^g   Niskanen, Leo ^h   Saaristo, Timo ^g,i   Saltevo, Juha T ^j   Sundvall, Jouko ^a   Vanhala, Mauno ^k,l   Uusitupa, Matti ^h   Peltonen, Markku ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^d SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

ⁱ Finnish Diabetes Association   (Finland)

^j Central Finland Central Hospital   (Finland)

^k UNIVERSITY OF EASTERN FINLAND   (Finland)

^l JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; FATTY LIVER; FEMALE; FINLAND; HEALTH SURVEY; HUMAN; LIFESTYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PREVALENCE; RISK FACTOR;

AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; FINLAND; HEALTH SURVEYS; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHENOTYPE; PREVALENCE; RISK FACTORS;

EID: 80053375232     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-754     Document Type: Review

References (40)

1. Global and societal implications of the diabetes epidemic. Zimmet P, Alberti KG, Shaw J, Nature 2001 414 782 787 10.1038/414782a 11742409 (Pubitemid 34000780)
2. Fatty liver: a novel component of the metabolic syndrome. Kotronen A, Yki-Järvinen H, Arterioscler Thromb Vasc Biol 2008 28 27 38 17690317
3. Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20 000 Dutch men and women aged 20-65 years. van Dis I, Kromhout D, Geleijnse JM, Boer JM, Verschuren WM, Eur J Cardiovasc Prev Rehabil 2009 16 729 734 10.1097/HJR.0b013e328331dfc0 19809330
4. Report of a WHO Consultation. WHO, Geneva: World Health Organization 2000
5. High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. Saaristo TE, Barengo NC, Korpi-Hyövälti E, Oksa H, Puolijoki H, Saltevo JT, Vanhala M, Sundvall J, Saarikoski L, Peltonen M, Tuomilehto J, BMC Public Health 2008 8 423 10.1186/1471-2458-8-423 19113993
6. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Bluher M, Curr Opin Lipidol 2010 21 38 43 10.1097/MOL. 0b013e3283346ccc 19915462
7. Metabolic Syndrome and Insulin Resistance in Subjects with Morbid Obesity. Soverini V, Moscatiello S, Villanova N, Ragni E, Di Domizio S, Marchesini G, Obes Surg 2010 20 295 301 10.1007/s11695-009-9999-z 19841991
8. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR, Arch Intern Med 2008 168 1617 1624 10.1001/archinte.168.15.1617 18695075
9. The metabolically healthy but obese individual presents a favorable inflammation profile. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, Rabasa-Lhoret R, J Clin Endocrinol Metab 2005 90 4145 4150 10.1210/jc.2005-0482 15855252 (Pubitemid 41058189)
10. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman E T, J Clin Endocrinol Metab 2001 86 1020 1025 10.1210/jc.86.3.1020 11238480 (Pubitemid 32322976)
11. Identification and characterization of metabolically benign obesity in humans. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU, Arch Intern Med 2008 168 1609 1616 10.1001/archinte.168.15.1609 18695074
12. Clinical markers for the identification of metabolically healthy but obese individuals. Karelis AD, Brochu M, Rabasa-Lhoret R, Garrel D, Poehlman ET, Diabetes Obes Metab 2004 6 456 457 10.1111/j.1462-8902.2004.00377.x 15479222 (Pubitemid 39409797)
13. Metabolic and body composition factors in subgroups of obesity: what do we know? Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET, J Clin Endocrinol Metab 2004 89 2569 2575 10.1210/jc.2004-0165 15181025 (Pubitemid 38766333)
14. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. Aguilar-Salinas CA, Garcia EG, Robles L, Riano D, Ruiz-Gomez DG, Garcia-Ulloa AC, Melgarejo MA, Zamora M, Guillen-Pineda LE, Mehta R, Canizales-Quinteros S, Tusie Luna MT, Gomez-Perez FJ, J Clin Endocrinol Metab 2008 93 4075 4079 10.1210/jc.2007-2724 18682512
15. Are natural killer cells protecting the metabolically healthy obese patient? Lynch LA, O'Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O'Shea DB, Obesity (Silver Spring) 2009 17 601 605 10.1038/oby.2008.565
16. Are there persons who are obese, but metabolically healthy? Sims EA, Metabolism 2001 50 1499 1504 10.1053/meta.2001.27213 11735101 (Pubitemid 34007425)
17. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Messier V, Karelis AD, Robillard ME, Bellefeuille P, Brochu M, Lavoie JM, Rhabasa-Lhoret R, Metabolism 2010 59 20 24 10.1016/j.metabol.2009.06.020 19709695
18. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. Reaven GM, Lithell H, Landsberg L, N Engl J Med 1996 334 374 381 10.1056/NEJM199602083340607 8538710 (Pubitemid 26049592)
19. The metabolically obese, normal-weight individual revisited. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S, Diabetes 1998 47 699 713 10.2337/diabetes.47.5.699 9588440 (Pubitemid 28201798)
20. Characteristics of metabolically obese normal-weight (MONW) subjects. Conus F, Rabasa-Lhoret R, Peronnet F, Appl Physiol Nutr Metab 2007 32 4 12 10.1139/h06-092 17332780
21. National type 2 diabetes prevention programme in Finland: FIN-D2D. Saaristo T, Peltonen M, Keinänen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L, Oksa H, Korpi-Hyövälti E, Tuomilehto J, Int J Circumpolar Health 2007 66 101 112 17515250
22. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators, J Clin Epidemiol 1988 41 105 114 10.1016/0895-4356(88)90084-4 3335877 (Pubitemid 18069569)
23. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
24. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. WHO, Part 1. Diagnosis and Classification of Diabetes Mellitus 1999
25. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson D, Clin Chem 1972 18 499 502 4337382
26. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB, Circulation 2008 117 743 753 10.1161/CIRCULATIONAHA. 107.699579 18212285 (Pubitemid 351640675)
27. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group, Eur Heart J 2003 24 987 1003 10.1016/S0195-668X(03)00114-3 12788299 (Pubitemid 36712275)
28. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Lindström J, Tuomilehto J, Diabetes Care 2003 26 725 731 10.2337/diacare.26.3.725 12610029 (Pubitemid 36929335)
29. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, Lundbom N, Rissanen A, Ridderstråle M, Groop L, Orho-Melander M, Yki-Järvinen H, Gastroenterology 2009 137 865 872 10.1053/j.gastro.2009.06.005 19524579
30. Metabolically healthy obesity: different prevalences using different criteria. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P, Eur J Clin Nutr 2010 64 1043 51 10.1038/ejcn.2010.114 20628408
31. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB, J Clin Endocrinol Metab 2006 91 2906 2912 10.1210/jc.2006-0594 16735483 (Pubitemid 44271734)
32. Metabolically healthy but obese women: effect of an energy-restricted diet. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R, Diabetologia 2008 51 1752 1754 10.1007/s00125-008-1038-4 18504546
33. Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men. rnlöv J, Ingelsson E, Sundström J, Lind L, Circulation 2010 121 230 236 10.1161/CIRCULATIONAHA. 109.887521 20038741
34. Prevalence, metabolic features and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L, Ruotolo G, Perseghin G, Diabetes Care 2011 34 210 215 10.2337/dc10-0665 20937689
35. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Kahn R, Buse J, Ferrannini E, Stern M, Diabetes Care 2005 28 2289 2304 10.2337/diacare.28.9.2289 16123508 (Pubitemid 41242486)
36. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. St-Pierre AC, Cantin B, Mauriege P, Bergeron J, Dagenais GR, Despres JP, Lamarche B, CMAJ 2005 172 1301 1305 10.1503/cmaj.1040834 15883404 (Pubitemid 40745071)
37. Trends in fatal and non-fatal coronary heart disease events in Finland during 1991-2001. Pajunen P, Pääkkönen R, Juolevi A, Hämäläinen H, Keskimäki I, Laatikainen T, Moltchanov V, Niemi M, Rintanen H, Salomaa V, Scand Cardiovasc J 2004 38 340 344 10.1080/14017430410010996 15804799 (Pubitemid 40142599)
38. Twenty-year changes in the prevalence of obesity among Finnish adults. Lahti-Koski M, Seppänen-Nuijten E, Männistö S, Härkänen T, Rissanen H, Knekt P, Rissanen A, Heliövaara M, Obes Rev 2010 11 171 176 10.1111/j.1467-789X.2009.00681.x 19874529
39. Thirty five year trends in cardiovascular risk factors in Finland: results from the National FINRISK Study. Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Männistö S, Sundvall J, Int J Epidemiol 2010 39 504 518 10.1093/ije/dyp330 19959603
40. The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 Study. Pajunen P, Rissanen H, Härkänen T, Jula A, Reunanen A, Salomaa V, Diabetes Metab 2010 36 395 401 10.1016/j.diabet.2010.04.003 20673644